C07J 21/006
At position 3
Official title: {at position 3}
C07J21/006 (At position 3) appears on 185 US grants and 88 published applications in this corpus.
Search patents in C07J- Granted patents
- 185
- Published applications
- 88
- Assignees
- 75
- Inventors
- 363
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 6 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 7 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 9 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 8 | 0 |
| 1994 | 5 | 0 |
| 1995 | 12 | 0 |
| 1996 | 5 | 0 |
| 1997 | 10 | 0 |
| 1998 | 10 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 5 |
| 2004 | 1 | 0 |
| 2005 | 3 | 4 |
| 2006 | 1 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 2 | 2 |
| 2011 | 3 | 1 |
| 2012 | 2 | 3 |
| 2013 | 1 | 5 |
| 2014 | 0 | 4 |
| 2015 | 5 | 5 |
| 2016 | 2 | 5 |
| 2017 | 4 | 4 |
| 2018 | 2 | 3 |
| 2019 | 4 | 5 |
| 2020 | 3 | 5 |
| 2021 | 5 | 10 |
| 2022 | 3 | 2 |
| 2023 | 2 | 4 |
| 2024 | 0 | 4 |
| 2025 | 2 | 7 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- Method for synthesizing ursodeoxycholic acid using BA as raw material14 Oct 2025US 12,441,759 B2Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
- Neuroactive steroids, compositions, and uses thereof10 Oct 2023US 11,780,875 B2Sage Therapeutics, Inc.
- Methods for onapristone synthesis dehydration and deprotection28 Mar 2023US 11,613,555 B2Context Biopharma Inc.
- Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid25 Oct 2022US 11,479,577 B2NZP UK Limited
- Compositions and methods for treating cns disorders9 Apr 2026US 2026/0098053 A1Sage Therapeutics, Inc.
- Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same5 Feb 2026US 2026/0034146 A1Sage Therapeutics, Inc.
- Intermediate compound and preparation method therefor and application thereof25 Sep 2025US 2025/0296950 A1Hunan Kyf Pharmaceutical Co., Ltd.
- GPX4 Inhibitors and Senolytic Compounds and Uses Thereof25 Sep 2025US 2025/0296951 A1
- C25 r and s isomers of aminosterols and methods of making and using the same17 Jul 2025US 2025/0228873 A1Enterin, Inc.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Novel steroids61US 4,386,085 ARoussell Uclaf · 1983
- Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof54US 7,196,074 B2The United States of America as represented by the Department of Health and Human Services · 2007
- Method of treatment of androgen-related diseases48US 5,372,996 AEndorecherche, Inc. · 1994
- Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same48US 9,630,986 B2Sage Therapeutics, Inc. · 2017